Report Detail
Global Afatinib Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024
- RnM3574662 |
- 04 July, 2019 |
- Global |
- 106 Pages |
- GIR (Global Info Research) |
- Pharma & Healthcare
Scope of the Report:
The worldwide market for Afatinib is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study.
This report focuses on the Afatinib in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
Boehringer Ingelheim
Hengrui Medicine
Beacon Pharma
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
30mg Tables
40mg Tables
50mg Tables
25mg Tables
20mg Tables
Other
Market Segment by Applications, can be divided into
Hospital
Clinic
Drug Center
Other
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Afatinib product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Afatinib, with price, sales, revenue and global market share of Afatinib in 2017 and 2018.
Chapter 3, the Afatinib competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Afatinib breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Afatinib market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Afatinib sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
- 1.1 Afatinib Introduction
- 1.2 Market Analysis by Type
- 1.2.1 30mg Tables
- 1.2.2 40mg Tables
- 1.2.3 50mg Tables
- 1.2.4 25mg Tables
- 1.2.5 20mg Tables
- 1.2.6 Other
- 1.3 Market Analysis by Applications
- 1.3.1 Hospital
- 1.3.2 Clinic
- 1.3.3 Drug Center
- 1.3.4 Other
- 1.4 Market Analysis by Regions
- 1.4.1 North America (United States, Canada and Mexico)
- 1.4.1.1 United States Market States and Outlook (2014-2024)
- 1.4.1.2 Canada Market States and Outlook (2014-2024)
- 1.4.1.3 Mexico Market States and Outlook (2014-2024)
- 1.4.2 Europe (Germany, France, UK, Russia and Italy)
- 1.4.2.1 Germany Market States and Outlook (2014-2024)
- 1.4.2.2 France Market States and Outlook (2014-2024)
- 1.4.2.3 UK Market States and Outlook (2014-2024)
- 1.4.2.4 Russia Market States and Outlook (2014-2024)
- 1.4.2.5 Italy Market States and Outlook (2014-2024)
- 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
- 1.4.3.1 China Market States and Outlook (2014-2024)
- 1.4.3.2 Japan Market States and Outlook (2014-2024)
- 1.4.3.3 Korea Market States and Outlook (2014-2024)
- 1.4.3.4 India Market States and Outlook (2014-2024)
- 1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)
- 1.4.4 South America, Middle East and Africa
- 1.4.4.1 Brazil Market States and Outlook (2014-2024)
- 1.4.4.2 Egypt Market States and Outlook (2014-2024)
- 1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)
- 1.4.4.4 South Africa Market States and Outlook (2014-2024)
- 1.4.4.5 Turkey Market States and Outlook (2014-2024)
- 1.4.1 North America (United States, Canada and Mexico)
- 1.5 Market Dynamics
- 1.5.1 Market Opportunities
- 1.5.2 Market Risk
- 1.5.3 Market Driving Force
2 Manufacturers Profiles
- 2.1 Boehringer Ingelheim
- 2.1.1 Business Overview
- 2.1.2 Afatinib Type and Applications
- 2.1.2.1 Product A
- 2.1.2.2 Product B
- 2.1.3 Boehringer Ingelheim Afatinib Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
- 2.2 Hengrui Medicine
- 2.2.1 Business Overview
- 2.2.2 Afatinib Type and Applications
- 2.2.2.1 Product A
- 2.2.2.2 Product B
- 2.2.3 Hengrui Medicine Afatinib Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
- 2.3 Beacon Pharma
- 2.3.1 Business Overview
- 2.3.2 Afatinib Type and Applications
- 2.3.2.1 Product A
- 2.3.2.2 Product B
- 2.3.3 Beacon Pharma Afatinib Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
3 Global Afatinib Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)
- 3.1 Global Afatinib Sales and Market Share by Manufacturer (2017-2018)
- 3.2 Global Afatinib Revenue and Market Share by Manufacturer (2017-2018)
- 3.3 Market Concentration Rate
- 3.3.1 Top 3 Afatinib Manufacturer Market Share in 2018
- 3.3.2 Top 6 Afatinib Manufacturer Market Share in 2018
- 3.4 Market Competition Trend
4 Global Afatinib Market Analysis by Regions
- 4.1 Global Afatinib Sales, Revenue and Market Share by Regions
- 4.1.1 Global Afatinib Sales and Market Share by Regions (2014-2019)
- 4.1.2 Global Afatinib Revenue and Market Share by Regions (2014-2019)
- 4.2 North America Afatinib Sales and Growth Rate (2014-2019)
- 4.3 Europe Afatinib Sales and Growth Rate (2014-2019)
- 4.4 Asia-Pacific Afatinib Sales and Growth Rate (2014-2019)
- 4.5 South America Afatinib Sales and Growth Rate (2014-2019)
- 4.6 Middle East and Africa Afatinib Sales and Growth Rate (2014-2019)
5 North America Afatinib by Country
- 5.1 North America Afatinib Sales, Revenue and Market Share by Country
- 5.1.1 North America Afatinib Sales and Market Share by Country (2014-2019)
- 5.1.2 North America Afatinib Revenue and Market Share by Country (2014-2019)
- 5.2 United States Afatinib Sales and Growth Rate (2014-2019)
- 5.3 Canada Afatinib Sales and Growth Rate (2014-2019)
- 5.4 Mexico Afatinib Sales and Growth Rate (2014-2019)
6 Europe Afatinib by Country
- 6.1 Europe Afatinib Sales, Revenue and Market Share by Country
- 6.1.1 Europe Afatinib Sales and Market Share by Country (2014-2019)
- 6.1.2 Europe Afatinib Revenue and Market Share by Country (2014-2019)
- 6.2 Germany Afatinib Sales and Growth Rate (2014-2019)
- 6.3 UK Afatinib Sales and Growth Rate (2014-2019)
- 6.4 France Afatinib Sales and Growth Rate (2014-2019)
- 6.5 Russia Afatinib Sales and Growth Rate (2014-2019)
- 6.6 Italy Afatinib Sales and Growth Rate (2014-2019)
7 Asia-Pacific Afatinib by Country
- 7.1 Asia-Pacific Afatinib Sales, Revenue and Market Share by Country
- 7.1.1 Asia-Pacific Afatinib Sales and Market Share by Country (2014-2019)
- 7.1.2 Asia-Pacific Afatinib Revenue and Market Share by Country (2014-2019)
- 7.2 China Afatinib Sales and Growth Rate (2014-2019)
- 7.3 Japan Afatinib Sales and Growth Rate (2014-2019)
- 7.4 Korea Afatinib Sales and Growth Rate (2014-2019)
- 7.5 India Afatinib Sales and Growth Rate (2014-2019)
- 7.6 Southeast Asia Afatinib Sales and Growth Rate (2014-2019)
8 South America Afatinib by Country
- 8.1 South America Afatinib Sales, Revenue and Market Share by Country
- 8.1.1 South America Afatinib Sales and Market Share by Country (2014-2019)
- 8.1.2 South America Afatinib Revenue and Market Share by Country (2014-2019)
- 8.2 Brazil Afatinib Sales and Growth Rate (2014-2019)
- 8.3 Argentina Afatinib Sales and Growth Rate (2014-2019)
- 8.4 Colombia Afatinib Sales and Growth Rate (2014-2019)
9 Middle East and Africa Afatinib by Countries
- 9.1 Middle East and Africa Afatinib Sales, Revenue and Market Share by Country
- 9.1.1 Middle East and Africa Afatinib Sales and Market Share by Country (2014-2019)
- 9.1.2 Middle East and Africa Afatinib Revenue and Market Share by Country (2014-2019)
- 9.2 Saudi Arabia Afatinib Sales and Growth Rate (2014-2019)
- 9.3 Turkey Afatinib Sales and Growth Rate (2014-2019)
- 9.4 Egypt Afatinib Sales and Growth Rate (2014-2019)
- 9.5 Nigeria Afatinib Sales and Growth Rate (2014-2019)
- 9.6 South Africa Afatinib Sales and Growth Rate (2014-2019)
10 Global Afatinib Market Segment by Type
- 10.1 Global Afatinib Sales, Revenue and Market Share by Type (2014-2019)
- 10.1.1 Global Afatinib Sales and Market Share by Type (2014-2019)
- 10.1.2 Global Afatinib Revenue and Market Share by Type (2014-2019)
- 10.2 30mg Tables Sales Growth and Price
- 10.2.1 Global 30mg Tables Sales Growth (2014-2019)
- 10.2.2 Global 30mg Tables Price (2014-2019)
- 10.3 40mg Tables Sales Growth and Price
- 10.3.1 Global 40mg Tables Sales Growth (2014-2019)
- 10.3.2 Global 40mg Tables Price (2014-2019)
- 10.4 50mg Tables Sales Growth and Price
- 10.4.1 Global 50mg Tables Sales Growth (2014-2019)
- 10.4.2 Global 50mg Tables Price (2014-2019)
- 10.5 25mg Tables Sales Growth and Price
- 10.5.1 Global 25mg Tables Sales Growth (2014-2019)
- 10.5.2 Global 25mg Tables Price (2014-2019)
- 10.6 20mg Tables Sales Growth and Price
- 10.6.1 Global 20mg Tables Sales Growth (2014-2019)
- 10.6.2 Global 20mg Tables Price (2014-2019)
- 10.7 Other Sales Growth and Price
- 10.7.1 Global Other Sales Growth (2014-2019)
- 10.7.2 Global Other Price (2014-2019)
11 Global Afatinib Market Segment by Application
- 11.1 Global Afatinib Sales Market Share by Application (2014-2019)
- 11.2 Hospital Sales Growth (2014-2019)
- 11.3 Clinic Sales Growth (2014-2019)
- 11.4 Drug Center Sales Growth (2014-2019)
- 11.5 Other Sales Growth (2014-2019)
12 Afatinib Market Forecast (2019-2024)
- 12.1 Global Afatinib Sales, Revenue and Growth Rate (2019-2024)
- 12.2 Afatinib Market Forecast by Regions (2019-2024)
- 12.2.1 North America Afatinib Market Forecast (2019-2024)
- 12.2.2 Europe Afatinib Market Forecast (2019-2024)
- 12.2.3 Asia-Pacific Afatinib Market Forecast (2019-2024)
- 12.2.4 South America Afatinib Market Forecast (2019-2024)
- 12.2.5 Middle East and Africa Afatinib Market Forecast (2019-2024)
- 12.3 Afatinib Market Forecast by Type (2019-2024)
- 12.3.1 Global Afatinib Sales Forecast by Type (2019-2024)
- 12.3.2 Global Afatinib Market Share Forecast by Type (2019-2024)
- 12.4 Afatinib Market Forecast by Application (2019-2024)
- 12.4.1 Global Afatinib Sales Forecast by Application (2019-2024)
- 12.4.2 Global Afatinib Market Share Forecast by Application (2019-2024)
13 Sales Channel, Distributors, Traders and Dealers
- 13.1 Sales Channel
- 13.1.1 Direct Marketing
- 13.1.2 Indirect Marketing
- 13.1.3 Marketing Channel Future Trend
- 13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
- 15.1 Methodology
Summary:
Get latest Market Research Reports on Afatinib . Industry analysis & Market Report on Afatinib is a syndicated market report, published as Global Afatinib Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024. It is complete Research Study and Industry Analysis of Afatinib market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
